BRIEF-Acasti Pharma Q2 loss per share $0.22

Tue Oct 11, 2016 5:48pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 11 (Reuters) - Acasti Pharma Inc

* reports second quarter 2017 financial results

* Qtrly loss per share $0.22

* if co does not raise additional funds, there exists uncertainty that casts substantial doubt about ability to continue as going concern

* Management has reasonable expectation that corporation will be able to raise additional funds Source text for Eikon: Further company coverage: